Alopecia universalis following human papillomavirus vaccine administration: a case report. [PDF]
Clin Exp Vaccine ResThe 9-valent human papillomavirus vaccine (9vHPV) protects against 9 HPV genotypes linked to cervical cancer and genital warts. While rare, HPV vaccines may trigger autoimmune reactions.
Wu Y, Liu X, Qiao J, Fang H.
europepmc +2 more sources
Successful treatment of concomitant alopecia universalis and Crohn's disease with upadacitinib: A case report. [PDF]
SAGE Open Med Case Rep, 2023 Alopecia areata is a non-scarring, autoimmune hair loss disorder that is associated with inflammatory bowel disease. Alopecia areata and inflammatory bowel disease may have a common pathogenic mechanism that involves the Janus kinase/STAT pathway.
Johnston LA, Lu C, Poelman SM.
europepmc +2 more sources
Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report. [PDF]
SAGE Open Med Case Rep, 2023 Alopecia universalis is a severe, difficult to treat variant of alopecia areata that results in loss of hair on the scalp, eyebrows, eyelashes, and extremities.
Oliel S +3 more
europepmc +2 more sources
Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review. [PDF]
Acta Derm Venereol, 2023 is missing (Short communication)
Yu D, Ren Y.
europepmc +2 more sources
Alopecia areata universalis in a dog [PDF]
Veterinary Dermatology, 2015 BackgroundAlopecia areata is a T‐cell mediated autoimmune disease that occurs in humans and various other mammalian species. When the disease progresses to total alopecia it is defined as alopecia areata universalis (AAU), although this outcome has only been described in humans.Hypothesis/objectivesTo describe a case of canine alopecia areata ...
Pedro J. Ginel +4 more
openalex +3 more sources
Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis. [PDF]
SAGE Open Med Case Rep, 2023 Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Osman S, Traboulsi D.
europepmc +2 more sources
Autoimmune Polyglandular Syndrome Type 2 Presentation with Alopecia Universalis, Hashimoto's Disease, and Addison's Disease. [PDF]
Int Med Case Rep JAutoimmune polyglandular syndrome type 2 (APS2) is characterized by the coexistence of primary adrenal insufficiency with autoimmune thyroid disease and/or type 1 diabetes.
Sales-Morales KD +3 more
europepmc +2 more sources
JAMA Dermatol, 2023 Importance Prevalences of alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) are poorly established. Objective To estimate overall and subgroup prevalences of AA and its subtypes.
Sy N, Mastacouris N, Strunk A, Garg A.
europepmc +2 more sources
Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata. [PDF]
Dermatol Ther (Heidelb), 2023 Alopecia areata (AA) is a cell-mediated autoimmune disease in which a cytotoxic T-cell response against hair follicles occurs. AA has been demonstrated to frequently co-exist with atopic dermatitis (AD), and the coincidence of atopy predisposes to a more
Kołcz K +3 more
europepmc +2 more sources
A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme. [PDF]
Vaccines (Basel), 2023 COVID-19 vaccines have positively changed the course of the pandemic. They entered the market after only one year of the initial trials, which that yielded positive results in terms of safety and efficacy. However, after inoculating billions of people in
Hernández Arroyo J +2 more
europepmc +2 more sources